Published in Am Rev Respir Dis on June 01, 1991
Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax (2003) 3.62
A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma. Am J Respir Crit Care Med (2006) 2.88
Effect of occupational exposures on decline of lung function in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 2.48
Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health (1995) 2.16
Beta 2-adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics. Hum Genet (2006) 1.43
Spirometry in primary care. Can Respir J (2013) 1.38
Admixture-matched case-control study: a practical approach for genetic association studies in admixed populations. Hum Genet (2005) 1.27
Spirometry testing standards in spinal cord injury. Chest (2003) 1.22
Vitamin D status and longitudinal lung function decline in the Lung Health Study. Eur Respir J (2010) 1.18
Asthma outcomes: pulmonary physiology. J Allergy Clin Immunol (2012) 1.02
Limits of longitudinal decline for the interpretation of annual changes in FEV1 in individuals. Occup Environ Med (2007) 0.97
Canadian prediction equations of spirometric lung function for Caucasian adults 20 to 90 years of age: results from the Canadian Obstructive Lung Disease (COLD) study and the Lung Health Canadian Environment (LHCE) study. Can Respir J (2011) 0.96
Spirometry Longitudinal Data Analysis Software (SPIROLA) for Analysis of Spirometry Data in Workplace Prevention or COPD Treatment. Open Med Inform J (2010) 0.92
Interferon gamma polymorphisms and their interaction with smoking are associated with lung function. Hum Genet (2006) 0.89
Quality of routine spirometry tests in Dutch general practices. Br J Gen Pract (2009) 0.89
Airflow obstruction in young adults in Canada. Can Respir J (2007) 0.86
Chronic productive cough is associated with death in smokers with early COPD. COPD (2013) 0.86
Effect of e-learning and repeated performance feedback on spirometry test quality in family practice: a cluster trial. Ann Fam Med (2011) 0.86
NFE2L2 pathway polymorphisms and lung function decline in chronic obstructive pulmonary disease. Physiol Genomics (2012) 0.81
A novel scoring system to measure radiographic abnormalities and related spirometric values in cured pulmonary tuberculosis. PLoS One (2013) 0.81
Effect of gene environment interactions on lung function and cardiovascular disease in COPD. Int J Chron Obstruct Pulmon Dis (2011) 0.80
Calibrating the calibrators. Thorax (1996) 0.78
Airflow limitation as a risk factor for low bone mineral density and hip fracture. Eur Clin Respir J (2016) 0.75
Modeling asthma exacerbations through lung function in children. J Allergy Clin Immunol (2012) 0.75
Serum Bilirubin and Disease Progression in Mild COPD. Chest (2015) 0.75
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med (2001) 27.83
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA (1994) 10.46
The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med (1992) 8.53
Global burden of COPD: systematic review and meta-analysis. Eur Respir J (2006) 7.00
Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax (2003) 4.81
Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med (2001) 4.48
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Construction and implantation of a permanent cannula for making injections into the lateral ventricle of the rat brain. Life Sci (1966) 3.54
Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med (2000) 3.43
Error in smoking measures: effects of intervention on relations of cotinine and carbon monoxide to self-reported smoking. The Lung Health Study Research Group. Am J Public Health (1993) 3.38
Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest (1999) 3.28
Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest (2000) 3.12
Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J (2002) 3.06
Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers. Eur Respir J (2006) 2.85
The one-year surgical outcome after prism adaptation for the management of acquired esotropia. Ophthalmology (1996) 2.76
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
A dynamic population model of disease progression in COPD. Eur Respir J (2005) 2.59
Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J (2009) 2.52
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med (1999) 2.36
Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience (2004) 2.30
Specialty differences in the management of asthma. A cross-sectional assessment of allergists' patients and generalists' patients in a large HMO. Arch Intern Med (1997) 2.28
Bronchodilator response in the lung health study over 11 yrs. Eur Respir J (2005) 2.26
Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health (1995) 2.16
The trophic action of gastrointestinal hormones. Gastroenterology (1976) 2.13
A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med (1994) 2.11
Early and late weight gain following smoking cessation in the Lung Health Study. Am J Epidemiol (1998) 2.10
Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial. Ann Intern Med (2001) 2.06
Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med (2001) 2.03
Associations of IL6 polymorphisms with lung function decline and COPD. Thorax (2009) 2.00
Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med (1996) 1.96
Predicted values for closing volumes using a modified single breath nitrogen test. Am Rev Respir Dis (1973) 1.89
Association of MSX1 and TGFB3 with nonsyndromic clefting in humans. Am J Hum Genet (1998) 1.89
Present and future costs of COPD in Iceland and Norway: results from the BOLD study. Eur Respir J (2009) 1.89
Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults. Thorax (2000) 1.88
Predictors of initial smoking cessation and relapse through the first 2 years of the Lung Health Study. J Consult Clin Psychol (1995) 1.86
Chronic Obstructive Pulmonary Disease Early Intervention Trial (Lung Health Study). Baseline characteristics of randomized participants. Chest (1993) 1.85
Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis (1993) 1.82
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J (2008) 1.76
Assessment of occupational exposure to inorganic arsenic based on urinary concentrations and speciation of arsenic. Br J Ind Med (1990) 1.75
New aspects of the trophic action of gastrointestinal hormones. Gastroenterology (1977) 1.74
Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers. Thorax (2001) 1.72
Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration. Chest (1994) 1.71
Preventing deaths from asthma. N Engl J Med (1994) 1.70
Secretin: the enterogastrone released by acid in the duodenum. Am J Physiol (1968) 1.62
Structural and hormonal alterations in the gastrointestinal tract of parenterally fed rats. Gastroenterology (1975) 1.61
Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease? Int J Tuberc Lung Dis (2009) 1.60
Quantitative analysis of the alveolar plateau in the diagnosis of early airway obstruction. Am Rev Respir Dis (1973) 1.56
Pentagastrin-induced stimulation of protein synthesis in the gastrointestinal tract. Am J Physiol (1969) 1.56
Restricted spirometry in the Burden of Lung Disease Study. Int J Tuberc Lung Dis (2012) 1.55
Intestinal hormones as inhibitors of gastric secretion. Gastroenterology (1971) 1.55
Stimulation of pancreatic growth by secretin, caerulein, and pentagastrin. Endocrinology (1980) 1.54
Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med (1998) 1.53
The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group. Am Rev Respir Dis (1992) 1.53
Relative impact of smoking and reduced pulmonary function on peptic ulcer risk. A prospective study of Japanese men in Hawaii. Gastroenterology (1989) 1.52
Monitoring recruitment effectiveness and cost in a clinical trial. Control Clin Trials (1993) 1.49
Perfluorocarbon priming and surfactant: physiologic and pathologic effects. Crit Care Med (1999) 1.48
Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group. Chest (1996) 1.45
The relationship between patterns of alcohol consumption and body weight. Lung Health Study Research Group. Int J Epidemiol (1995) 1.43
Associations of smoking with hospital-based care and quality of life in patients with obstructive airway disease. Chest (1999) 1.42
COPD exacerbations: the importance of a standard definition. Respir Med (2004) 1.42
Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med (1994) 1.42
Recruiting hard-to-reach subjects: is it worth the effort? Control Clin Trials (1994) 1.41
Rho proteins play a critical role in cell migration during the early phase of mucosal restitution. J Clin Invest (1997) 1.40
20-year trends in the prevalence of asthma and chronic airflow obstruction in an HMO. Am J Respir Crit Care Med (1998) 1.40
Partial liquid ventilation: a comparison using conventional and high-frequency techniques in an animal model of acute respiratory failure. Crit Care Med (1997) 1.40
Effects of smoking and smoking cessation on longitudinal decline in pulmonary function. Am J Respir Crit Care Med (1995) 1.40
Caesarean section delivery and the risk of allergic disorders in childhood. Clin Exp Allergy (2005) 1.36
Responses of black and white males to the special intervention program of the Multiple Risk Factor Intervention Trial. Am Heart J (1984) 1.33
Stimulation of growth of a colon cancer cell line by gastrin. Am J Physiol (1986) 1.33
A comparison of conventional spirometric tests and the test of closing volume in an emphysema screening center. Am Rev Respir Dis (1973) 1.30
Prospective study of pulmonary function and lung cancer. Am Rev Respir Dis (1991) 1.29
Effect of secretin on acid and pepsin secretion in cat and dog. Gastroenterology (1969) 1.28
Effect of cholecystokinin on myoelectric activity of small bowel of the dog. Am J Physiol (1977) 1.27
The effect of smoking cessation and modification on lung function. Am Rev Respir Dis (1976) 1.26
Polyamine depletion arrests cell cycle and induces inhibitors p21(Waf1/Cip1), p27(Kip1), and p53 in IEC-6 cells. Am J Physiol (1999) 1.24
Effects of gastrointestinal hormones on pancreatic growth. Cancer (1981) 1.24
Migration of IEC-6 cells: a model for mucosal healing. Am J Physiol (1992) 1.24
Further investigation into the recent increase in asthma death rates: a review of 41 asthma deaths in Oregon in 1982. Ann Allergy (1988) 1.22
Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA (1993) 1.21
Vitamin D status and longitudinal lung function decline in the Lung Health Study. Eur Respir J (2010) 1.18
RNA and DNA of gastric and duodenal mucosa in antrectomized and gastrin-treated rats. Am J Physiol (1973) 1.18
Effect of vagotomy on electrical activity of the small intestine of the dog. Am J Physiol (1975) 1.18
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med (1981) 1.17
Identification of the transactivation domain of the transcription factor Sox-2 and an associated co-activator. J Biol Chem (2000) 1.16
Effect of cholecystokinin and caerulein on gastrin- and histamine-evoked gastric secretion. Gastroenterology (1969) 1.16
Decreased expression of protooncogenes c-fos, c-myc, and c-jun following polyamine depletion in IEC-6 cells. Am J Physiol (1993) 1.16
Analysis of inhibition of acid secretion by cholecystokinin in dogs. Am J Physiol (1970) 1.16